Harmony Biosciences Holdings, Inc.
HRMY
$38.05
$0.882.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 57.32% | 10.91% | 12.91% | -18.66% | -42.57% |
| Total Depreciation and Amortization | -2.20% | -1.90% | -1.01% | -0.14% | 0.61% |
| Total Amortization of Deferred Charges | -62.40% | -66.34% | -69.22% | -71.49% | 6.55% |
| Total Other Non-Cash Items | -43.65% | 77.09% | 96.90% | 220.49% | 206.22% |
| Change in Net Operating Assets | 329.28% | -217.24% | -120.90% | 129.97% | 3,295.19% |
| Cash from Operations | 21.47% | 7.07% | 0.20% | 30.42% | 32.21% |
| Capital Expenditure | 12.90% | -302.52% | -269.55% | -264.39% | -155.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 10.54% | 10.54% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.18% | -81.47% | -263.12% | 55.17% | 69.37% |
| Cash from Investing | 75.83% | -15.94% | -45.32% | -68.26% | -10.14% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 92.78% | 92.67% | 92.55% | 92.42% | -10,287.50% |
| Issuance of Common Stock | 987.50% | 778.84% | 28.61% | -56.29% | -88.73% |
| Repurchase of Common Stock | 95.44% | 96.21% | 97.52% | 0.49% | -19,407.59% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | 93.99% | 93.15% | 89.58% | -25.13% | -1,587.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 231,164.65% | 250.29% | 109.72% | 0.04% | -100.12% |